SAN FRANCISCO — When administering anti-VEGF treatments to patients with wet age-related macular degeneration, diabetic macular edema or retinal vein occlusion who have severe glaucoma, be mindful of the speed and volume of injections.
At Retina Subspecialty Day at the American Academy of Ophthalmology meeting, Rajendra S. Apte, MD, PhD, said that in patients with severe or unstable glaucoma, treatment of underlying conditions such as narrow angles is essential. Monitoring of pretreatment procedures is also imperative.
“I can’t tell you how many patients stop their glaucoma